Charles L. Raison

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

Charles L. Raison, Robin E. Rutherford, Bobbi J. Woolwine et al. · JAMA Psychiatry · 2012 · 1.6K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

American Gut: an Open Platform for Citizen Science Microbiome Research

Daniel McDonald, Embriette R. Hyde, Justine W. Debelius et al. · mSystems · 2018 · 906 citations · Full text

Life Sciences, Microbiology, Metabolomics +16

Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress

Thaddeus W. W. Pace, Lobsang Tenzin Negi, Daniel D. Adame et al. · Psychoneuroendocrinology · 2008 · 753 citations · Full text

Nursing, Neuroscience, Psychology +17

Single-Dose Psilocybin Treatment for Major Depressive Disorder

Charles L. Raison, Gerard Sanacora, Joshua Woolley et al. · JAMA · 2023 · 484 citations · Full text

Medicine, Pharmacology, Psychiatry +11

Effects of mindful-attention and compassion meditation training on amygdala response to emotional stimuli in an ordinary, non-meditative state

Gaëlle Desbordes, Lobsang Tenzin Negi, Thaddeus W. W. Pace et al. · Frontiers in Human Neuroscience · 2012 · 440 citations · Full text

Life Sciences, Neuroscience, Psychology +15